Biocon informs about press release

22 Jun 2020 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Biocon has informed that it has enclosed the press release as on 22nd June 2020 titled ‘Pharma and DKSH Collaborate to commercialize seven generic formulations in South East Asia markets’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

387.30 -3.25 (-0.83%)
16-Dec-2025 10:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.50
Dr. Reddys Lab 1273.50
Cipla 1500.40
Zydus Lifesciences 923.90
Lupin 2089.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×